Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

PHOENIX, Arizona and OSLO, Norway — November 21, 2022 — Scientists at the Phoenix-based Translational Genomics Research Institute (TGen), part of City of Hope, and EXACT Therapeutics AS (“EXACT-Tx”, Euronext Growth: EXTX), a Norwegian clinical stage precision health company, today report that the ultrasound based Acoustic Cluster Therapy (ACT®) significantly enhanced the antitumor efficacy of standard care therapies in a preclinical model for pancreatic cancer.Continue reading

New Study Identifies Connection Between Diabetes Medications, Multiple Sclerosis

Researchers at the Center for Innovation in Brain Science examined the impact of medication exposure in people with Type 2 diabetes on the risk of developing multiple sclerosis.

The study found that anti-hyperglycemic medications used to treat Type 2 diabetes resulted in an increased risk of multiple sclerosis for people older than 45, particularly among women.Continue reading

AZ FAST Grants – Apply by Dec 31 2022

FEDERAL AND STATE TECHNOLOGY (FAST) PARTNERSHIP PROGRAM

The Arizona Commerce Authority has partnered with the Small Business Administration to facilitate the SBIR program in Arizona. Arizona’s FAST program provides funds, resources, training, and network opportunities to help entrepreneurs succeed in their SBIR proposal.

Please note: FAST Grant funding is only available to Arizona businesses seeking an SBIR-funded grant. FAST Grant applications are being accepted through December 31, 2022.

 

  LEARN MORE